Diheterospora chlamydospora in Poland
نویسندگان
چکیده
منابع مشابه
Real-time PCR detection of Phaeomoniella chlamydospora and Phaeoacremonium aleophilum.
Phaeomoniella chlamydospora and Phaeoacremonium aleophilum are the two main fungal causal agents of Petri disease and esca. Both diseases cause significant economic losses to viticulturalists. Since no curative control measures are known, proactive defensive measures must be taken. An important aspect of current research is the development of sensitive and time-saving protocols for the detectio...
متن کاملCutaneous alternariosis due to Alternaria chlamydospora after bone marrow transplantation.
In June 1994, a 33-year-old man was diagnosed with chronic myelogenous leukaemia. In November 1995, he underwent an allogeneic BMT from an unrelated donor. Three months later, a slightly itchy erythematous papule appeared on his left leg. During the following days, 2 similar lesions developed on his left thigh and right arm (Fig. 1). The lesions increased a little in size and the centre of the ...
متن کاملmining in poland
poland is a traditional mining country ranking high in europian mining. a considerable part of polish national-gross-product comes from mineral resources. a large number of the working people work in the mines and related industry. research and educational centers depending on mining are well grown and are of great importance. the major mining commodities of poland are: coal, brown coal copper,...
متن کاملNurse prescribing in Poland
The aim of this study was to identify and examine the differences in opinions held by health care professionals and the general public concerning the right to administer and prescribe medication which has been awarded to nurses and midwives in Poland.The study was conducted from December 1, 2014 to July 1, 2015, in randomly selected primary health care clinics, among 2227 individuals, including...
متن کاملDrug Policy in Poland.
We presented a general overview of the health care system as well as the pricing and reimbursement environment in Poland. Poland aims to ensure proper access to safe and effective medicines while reducing patients' share in treatment costs. Nevertheless, the co-payment for pharmacotherapy is still high (more than 60%). The key policymaker and regulator in the system is the Ministry of Health, w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Mycologica
سال: 2014
ISSN: 2353-074X
DOI: 10.5586/am.1972.002